Skip to main content

MALARIA RESEARCH INSTITUTE

Leading Science for a Malaria-Free World 

Founded in May 2001 and continuously supported by Bloomberg Philanthropies, the Johns Hopkins Malaria Research Institute conducts discovery research at the Bloomberg School of Public Health in Baltimore and field research at the Macha Research Trust in Zambia and other sites of endemic malaria in sub-Saharan Africa, India, and elsewhere. 

The initial Bloomberg Philanthropies gift established a state-of-the-art research facility with the goal to treat and control malaria, develop a vaccine, and find new drug targets and innovative strategies to prevent and cure the deadly disease. The Institute has contributed to advances in all these areas and is one of the most comprehensive research endeavors focused on malaria globally.

News and Noteworthy

Science News

In the News

Malaria parasites can evade rapid tests. Mutations that render Plasmodium falciparum invisible to these tests are spreading globally. Director Jane Carlton quoted.

 

Newest Bloomberg Distinguished Professor

JHMRI Director Jane Carlton is JHU's newest BDP, Bloomberg Distinguished Professor of Malaria Genomics and Global Public Health.  

Applications Welcome

Two full-time, tenure-track faculty positions are open. Seeking candidates that use ‘omics’ technologies and systems biology approaches in their studies of the pathogen, the host, or vector.

130+

 Pilot grants awarded

750+

First- and last-authored publications since 2010 

Malaria Research in Action | A Video

Scientists at the Johns Hopkins Malaria Research Institute are working to better understand and fight malaria from the labs in Baltimore to the field in Southern and Central Africa.